PL2003978T3 - Terapia komórkami allogenicznymi do leczenia oportunistycznego zakażenia - Google Patents

Terapia komórkami allogenicznymi do leczenia oportunistycznego zakażenia

Info

Publication number
PL2003978T3
PL2003978T3 PL06750196T PL06750196T PL2003978T3 PL 2003978 T3 PL2003978 T3 PL 2003978T3 PL 06750196 T PL06750196 T PL 06750196T PL 06750196 T PL06750196 T PL 06750196T PL 2003978 T3 PL2003978 T3 PL 2003978T3
Authority
PL
Poland
Prior art keywords
treatment
cell therapy
opportunistic infection
allogeneic cell
allogeneic
Prior art date
Application number
PL06750196T
Other languages
English (en)
Inventor
Michael Har-Noy
Original Assignee
Immunovative Therapies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovative Therapies Ltd filed Critical Immunovative Therapies Ltd
Publication of PL2003978T3 publication Critical patent/PL2003978T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/44—Fungal antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL06750196T 2006-04-13 2006-04-13 Terapia komórkami allogenicznymi do leczenia oportunistycznego zakażenia PL2003978T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06750196.5A EP2003978B1 (en) 2006-04-13 2006-04-13 Allogeneic cell therapy for treatment of opportunistic infection
PCT/US2006/014088 WO2007120128A1 (en) 2006-04-13 2006-04-13 Allogeneic cell therapy for treatment of opportunistic infection

Publications (1)

Publication Number Publication Date
PL2003978T3 true PL2003978T3 (pl) 2014-12-31

Family

ID=38609793

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06750196T PL2003978T3 (pl) 2006-04-13 2006-04-13 Terapia komórkami allogenicznymi do leczenia oportunistycznego zakażenia

Country Status (11)

Country Link
EP (1) EP2003978B1 (pl)
JP (1) JP5254952B2 (pl)
CA (1) CA2649290C (pl)
CY (1) CY1115446T1 (pl)
DK (1) DK2003978T3 (pl)
ES (1) ES2482141T3 (pl)
IL (1) IL194667A (pl)
PL (1) PL2003978T3 (pl)
PT (1) PT2003978E (pl)
SI (1) SI2003978T1 (pl)
WO (1) WO2007120128A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7435592B2 (en) 2003-05-13 2008-10-14 Immunovative Therapies, Ltd. Compositions for allogeneic cell therapy
US20120128656A1 (en) * 2008-05-02 2012-05-24 Immunovative Therapies, Ltd. Vaccine compositions and methods
US20110250173A1 (en) * 2010-04-13 2011-10-13 Immunovative Therapies Ltd. Methods and compositions for inhibition of Treg cells
EP2601957B1 (en) * 2010-08-06 2019-04-10 Canine-Lab. Inc. Immunological function enhancing agent
PH12013502252B1 (en) 2011-05-03 2018-09-21 Immunovative Therapies Ltd Induction of il-12 using immunotherapy
TWI676481B (zh) * 2012-05-02 2019-11-11 以色列商梵提夫免疫療法公司 使用免疫療法誘導ｉｌ－１２
CA2782942C (en) 2012-07-12 2019-08-27 Canadian Blood Services Method for inducing immune tolerance using polymer-modified antigenic leukocytes
US11007221B2 (en) 2013-07-12 2021-05-18 Canadian Blood Services Acellular pro-inflammatory compositions, process for making same and methods of using same
CA2954440A1 (en) 2014-07-10 2016-01-14 Canadian Blood Services Combination therapy of acellular pro-tolerogenic and pro-inflammatory preparations for modulating the immune system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156312A (en) * 1993-06-23 2000-12-05 Leskovar; Peter Agents, affecting the hyperactivated immunological effector cells

Also Published As

Publication number Publication date
EP2003978B1 (en) 2014-06-11
CA2649290C (en) 2017-04-04
EP2003978A1 (en) 2008-12-24
SI2003978T1 (sl) 2014-11-28
DK2003978T3 (da) 2014-07-07
IL194667A (en) 2015-06-30
PT2003978E (pt) 2014-07-25
ES2482141T3 (es) 2014-08-01
JP2009533430A (ja) 2009-09-17
CA2649290A1 (en) 2007-10-25
CY1115446T1 (el) 2017-01-04
WO2007120128A1 (en) 2007-10-25
EP2003978A4 (en) 2009-07-22
JP5254952B2 (ja) 2013-08-07

Similar Documents

Publication Publication Date Title
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
BRPI0821779A2 (pt) tratamento terapêutico de câncer
BRPI0808191A2 (pt) dispositivos implantáveis híbridos terapêuticos
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
PL2037902T3 (pl) Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
HUE054196T2 (hu) Terápiás szerek nemkívánatos sejtproliferációhoz kapcsolódó betegségek kezelésére
DK2121139T3 (da) Formulations for cancer treatment
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
HUE045367T2 (hu) Kombinált terápia diabétesz kezelésére
GB0718446D0 (en) Compositions and methods for the treatment of infection
SI1874781T1 (sl) Dihidrotienopirimidini za zdravljenje vnetnih obolenj
HUE036071T2 (hu) Macitentánt tartalmazó terápiás készítmények
DK2173831T3 (da) Brøndbehandling
IL206588A0 (en) Device for the study of living cells
EP3381471C0 (en) PAIN TREATMENT
HUE046349T2 (hu) Kompozíciók rákos sejtek kezelésére, és ezek szintézise
HUE038563T2 (hu) Rák kezelési eljárás
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
CY2016019I2 (el) Θεραπευτικη αγωγη της σκληρυνσης κατα πλακας (ms) me campath-1h
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea